Results summary | View all lists in L2L MDB | View all genes in D09AA.profile.ud50 |
Down-regulated in human hepatoma cells (HepG2) following 24 hrs treatment with 2.5 microM 5-aza-2-deoxycytidine (5azaC) and 24 hrs treatment with both 5azaC and 500 nM trichostatin A (TSA). enrichment: 1.55-fold |
|||||||||||||
Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
220143_X_AT | LUC7L | LUC7-like (S. cerevisiae) | |||||||||||
218695_AT | EXOSC4 | R | exosome component 4 | ||||||||||
201925_S_AT | CD55 | X | P | CD55 molecule, decay accelerating factor for complement (Cromer blood group) | |||||||||
220149_AT | C2ORF54 | ||||||||||||
209409_AT | GRB10 | C | S | growth factor receptor-bound protein 10 | |||||||||
203574_AT | NFIL3 | X | R | nuclear factor, interleukin 3 regulated | |||||||||
213606_S_AT | ARHGDIA | G | C | S | Rho GDP dissociation inhibitor (GDI) alpha | ||||||||
202887_S_AT | DDIT4 | DNA-damage-inducible transcript 4 | |||||||||||
209921_AT | SLC7A11 | T | P | solute carrier family 7, (cationic amino acid transporter, y+ system) member 11 | |||||||||
217678_AT | SLC7A11 | T | P | solute carrier family 7, (cationic amino acid transporter, y+ system) member 11 | |||||||||
205048_S_AT | PSPH | phosphoserine phosphatase | |||||||||||
206028_S_AT | MERTK | P | C | S | c-mer proto-oncogene tyrosine kinase | ||||||||
212520_S_AT | SMARCA4 | R | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 | ||||||||||
212726_AT | PHF2 | PHD finger protein 2 | |||||||||||
212811_X_AT | SLC1A4 | T | solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 | ||||||||||
210105_S_AT | FYN | T | D | X | P | S | FYN oncogene related to SRC, FGR, YES | ||||||
221279_AT | GDAP1 | ganglioside-induced differentiation-associated protein 1 | |||||||||||
216361_S_AT | MYST3 | D | P | R | MYST histone acetyltransferase (monocytic leukemia) 3 |